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GE N E R A L AR T I C L E
The Legalization of Medical/Recreational
Marijuana: Implications for School Health
Drug Education Programs*
JOSEPH DONNELLY, PhDa MICHAEL YOUNG, PhD, FAAHB, FSSSS, FAAHE, FASHAb
ABSTRACT
BACKGROUND: More than half of US states have legalized medical marijuana. Several states have also legalized it for
recreational use. In spite of states’ actions, marijuana remains illegal under federal law. It remains to be seen, however, if the
Trump administration will enforce federal law in states that have legalized marijuana. For now, it appears the move toward state
legalization of marijuana will increase. Because of its legal status, research concerning the medical benefits of marijuana has
been limited.
METHODS: We reviewed the literature pertaining to medical use and legalization of marijuana.
RESULTS: Available research shows that marijuana can benefit some conditions. There are also concerns about harmful effects
on both individual and public health and whether legalization will lead to increased marijuana use among youth. Each of these
elements has implications for school-based drug education programs. Researchers have shown that the 10 states with the
highest rate of past month marijuana use by youth all have legalized recreational and/or medical use of marijuana, whereas
none of the 10 states with the lowest rate of past month marijuana use by youth, has legalized marijuana. In the debate over
legalization schools can potentially serve as a community resource, providing accurate information concerning marijuana.
CONCLUSIONS: Teachers and parents should continue to discourage young people from using marijuana (as well as alcohol,
tobacco, and other drugs).
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In 1996, California became the first US state tolegalize the use of medical marijuana. Since then,
another 28 states plus the District of Columbia, Guam,
and Puerto Rico have legalized medical marijuana.1
Not only has medical marijuana been legalized in most
states, 8 states and Washington, DC,2 led by Colorado
and Washington in 2012,3 have legalized recreational
use of marijuana. States have viewed the legalization
of marijuana as an economic boom. The industry is on
track to post $20.2 billion in annual sales by 2021.4
Everything seems to point to increased efforts to
making legal marijuana even more widely available.
Before we rush headlong into doing so, however,
it may be prudent to take a closer look at some
of the issues relative to this drug. Thus, in this
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paper we examine the legal status of marijuana, the
benefits and concerns about marijuana use, both as
a medicinal and as a recreational drug, the impact
of the legal availability of marijuana on adolescent
use of marijuana, and other substances, and the
implications that potentially even wider availability of




Although most states have provided legal access
to medical marijuana, and some of these states also
have legalized its recreational use, at the federal
Journal of School Health • September 2018, Vol. 88, No. 9 • © 2018, American School Health Association • 693
level, marijuana remains illegal. Differing messages,
however, have been given relative to enforcement
of the federal law. For example, under the Obama
administration, Attorneys General Eric Holder and
Loretta Lynch generally declined to challenge state
laws that legalized marijuana. Also, in response
to the legalization of marijuana in several states,
James Cole, the Deputy Attorney General, in August
2013, sent a memo to all US attorneys to provide
‘‘Guidance Regarding Marijuana Enforcement.’’ In the
memo, Cole reconfirmed several federal enforcement
priorities concerning marijuana. He made clear that
this guidance did ‘‘not alter in any way the
Department’s authority to enforce . . . federal laws
related to marijuana, regardless of state law.’’ At
the same time he indicated that individuals who
possessed small amounts of marijuana for personal use
on private property and those engaged in marijuana
operations, but were in compliance with the state law
in those jurisdictions that had ‘‘implemented strong
and effective regulatory and enforcement systems’’
were low priority.5 Finally, Congress passed a short-
term spending bill that included the Rohrabacher-Farr
Amendment (first passed in 2014). This amendment
prohibits the use of federal funds to prevent states from
‘‘implementing their own state laws that authorize the
use, distribution, possession, or cultivation of medical
marijuana.’’6 It also has been included in subsequent
federal spending bills, eg, in the disaster relief package
signed by President Trump on September 8, 2017.
This action allows the provisions of the amendment to
continue to be in effect for the period of the spending
bill but they will expire when the spending bill ends,
unless Congress votes to also include it in the next
spending bill.7
On the other side of the issue the US Drug
Enforcement Administration (DEA), in 2016, con-
firmed marijuana’s status as a Schedule I drug. The
agency indicated: (1) Marijuana has a high potential
for abuse; (2) Marijuana has no currently accepted
medical treatment use in the United States; and (3)
Marijuana lacks accepted safety for use under medical
supervision.8 Additionally in April of 2016, then Sen-
ator, now Attorney General, Jeff Sessions, at a Senate
hearing entitled, ‘‘Is the Department of Justice ade-
quately protecting the public from the impact of state
recreational marijuana legislation,’’ stated ‘‘ . . . good
people don’t smoke marijuana.’’ and ‘‘we need grown-
ups in charge in Washington to say marijuana is not
the kind of thing that ought to be legalized ... that
it is, in fact, a very real danger.’’9 In the January
2017 confirmation hearings, however, Sessions admit-
ted during questioning by his fellow US senators that
disrupting states’ legal marijuana markets by enforcing
federal marijuana laws could create an undue strain
on federal resources.10
However, the following month, in a White House
briefing, White House Press Secretary Sean Spicer
said the White House expects there will be greater
enforcement of federal laws concerning marijuana
in states that have legalized recreational marijuana.
He also noted that the President was supportive
of medical marijuana, but not recreational use of
marijuana.11
Since his confirmation as Attorney General, Jeff
Sessions has indicated he is opposed to the legal-
ization of marijuana, that marijuana continues to
be against federal law, including in states that have
legalized marijuana, and also stated that the Jus-
tice Department will enforce the law ‘‘in an appro-
priate way nationwide.’’12 He has also established
a taskforce that will provide a review of crime
reduction and public safety including a review of
marijuana.13
If there is a real effort by the federal government
to shut down existing marijuana operations, func-
tioning openly as legal businesses in the states that
have legalized the drug for recreational and/or medi-
cal purposes, the federal government can expect major
pushback from the states. States will make marijuana
a state’s rights issue. It appears likely, that over the
next few years, even more states will legalize mar-
ijuana for recreational and/or medical use. Pressure
by those who view marijuana as an important alter-
native/complementary treatment, states seeing mar-
ijuana tax money as a cure for budget woes, and
entrepreneurs viewing marijuana as an opportunity to
make big money will all be factors leading to increased
legalization.
As the legal landscape changes there are also
implications for the messages school health/drug
education programs provide young people about
marijuana. For example, is marijuana legal or not?
The current answer to that question is: ‘‘It depends.’’
What We Know About the Medical Benefits of Marijuana
Do the medical benefits of marijuana justify its
increased legal availability for medical purposes?
Because of the legal status of marijuana, research
related to the medical benefits has been relatively
limited. Research has, however, found marijuana
to have therapeutic potential in several areas.
For example, marijuana use has been found to
relieve chronic neuropathic pain.14,15 Also, researchers
have long recognized marijuana’s effect on appetite
stimulation in debilitating disease.16,17 Additionally,
research also has shown that an orally administered
cannabis extract can help multiple sclerosis patients
by reducing the frequency of muscle spasms and
increasing mobility,15,18,19 and that marijuana may
be effective in controlling nausea and vomiting caused
by chemotherapy in cancer patients.19,20 The National
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Academies of Sciences, Engineering, and Medicine also
indicated there is limited evidence that does suggest
that exposure to cannabis may have anti-inflammatory
activity.19
What Concerns Are Related to the Use of Medical
Marijuana
Whereas marijuana has been shown to have
medical benefits, we also know that marijuana
use has a number of negative side effects. Among
the most consistently seen side effects are an
increase in heart rate and an increase in systolic
blood pressure.21 There is also some evidence
suggesting that cannabis smoking may trigger a heart
attack.19 Other side effects include increased appetite,
increased thirst, drowsiness, insomnia, anxiety, panic
attacks, hallucinations, and short-term memory loss.21
Marijuana use also has been shown to produce changes
in in perception of time.22 Additionally the National
Institute on Drug Abuse has indicated marijuana
produces altered senses (eg, seeing brighter colors),
changes in mood, impaired body movement, and
difficulty with thinking and problem-solving.23
Research has suggested that smoking cannabis on
a regular basis is associated with more frequent
chronic bronchitis episodes and poorer respiratory
symptoms.19 Other researchers have noted that
marijuana smoke contains tar with carcinogens similar
to those in the tar from tobacco smoke.24 Although
it would seem that frequent smoking of marijuana
may, like tobacco, could have cancer-causing effects,
the report from the National Academies indicates that
existing evidence suggests cannabis does not increase
the risk for the type of cancers most often associated
with tobacco use. The report did, however, indicate
that cannabis use is associated with one subtype of
testicular cancer.19
We know that no one in the United States has ever
died directly from a documented case of marijuana
overdose,25 but many of the noted side effects can
contribute to serious injury or death. For example,
marijuana use can severely impair driving performance
while operating a motor vehicle,26 and research
indicates that cannabis use prior to driving increases
the risk of being involved in a motor vehicle crash.19
The Concerns About Legalizing Marijuana
for Recreational Use
One major concern about legalizing the recreational
use of marijuana is the possibility of increased
motor vehicle crashes due to marijuana intoxication.
Researchers in Washington state examined this issue.
They studied the prevalence of THC in the blood of
drivers involved in fatal crashes from 2010 to 2014.
They found that the proportion of drivers in fatal
crashes who had detectable amounts in the blood did
not increase immediately after legalization, but began
increasing rapidly in September 2013, about 9 months
after legalization. In 2014, the proportion of drivers
involved in fatal crashes who were identified as having
THC in their blood was double that of previous years.27
Colorado also has seen an increase in marijuana
related traffic deaths, reporting an increase in 62%
since recreational marijuana was legalized in 2013.
The percentage of marijuana-related traffic deaths, as
a percentage of all traffic deaths, has also increased.
For example, in 2009 traffic deaths involving drivers
who tested positive for marijuana represented 10%t of
all traffic deaths. In 2015 this had risen to 21%.28
Hospital emergency department visits have risen
since the legalization of recreational marijuana. In
Colorado, emergency department visits likely related
to marijuana use were 313/100,000 in 2011 and
358/100,000 in 2012. In 2013, the year recreational
marijuana was legalized the rate grew to 443/100,000.
In 2014 that rate was 554/100,000.28 Young children
have also been involved in marijuana exposure
visits to hospitals and poison centers. For example,
researchers in Colorado examined the rates of visits,
due to marijuana exposure, a single children’s hospital
and a regional poison center, both before and after
legalization of marijuana, among children less than
10 years of age. The median age of children visiting
the hospital was 2.4 years; the median age for those
visiting the poison center was 2 years. Rates for the
2 years prior to legalization were compared to the rates
2 years following legalization. At the hospital the mean
rate of visits prior to legalization was 1.2/100,000; the
rate following legalization was 2.3/100,000 (p = .02).
At the poison center the number of visits increased
from 9 in 2009 to 47 in 2015. Over half of the exposures
involved edible products and poor child supervision or
product storage was reported for a more than one-third
of the exposures.29
Another concern regarding the legalization of
marijuana has to do with the role of regulations
relative to public health and risk reduction, versus
a focus on profits, with little concern for public health.
Clearly marijuana is big business and we have seen
how big tobacco companies have for years placed
profits before public health.30 Pacula et al31 noted
states that have legalized marijuana are writing the
rules that will allow for the legal production and sale
of marijuana products, but that they are doing so
with no modern examples of marijuana regulation to
provide guidance. For example, what measures will
be taken to reduce: access, availability and use by
youth; driving under the influence; consumption of
products with unwanted contaminants and uncertain
potency; and risk of dependency and addiction? We do
have experience and lessons that have been learned
from examining public health approaches to regulating
alcohol and tobacco. It is unclear, however, the degree
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to which these lessons will be applied in developing
policy regarding marijuana sales. Neither is it clear as
to what research will be sponsored that will help us
understand the effects of these policies.
Legal Marijuana and Its Impact on Adolescent Use
and Use of Other Substances
A concern voiced by a number of authorities is
that the legal availability of marijuana for recreational
and/or medical purposes will lead the public, and
specifically young people, to believe that marijuana
use is safe. Additionally, there will be easier and more
widespread access to marijuana, and marketing efforts
targeting young people. The result will be an increase
in the use of marijuana for recreational purposes and
increased marijuana dependence among school-aged
youth.32
We also know that marijuana use is potentially more
problematic among adolescents than among older
adults. Adolescent use of marijuana is associated with
a number of different problems, including inattention,
academic learning, and processing speed; subtle
abnormalities in brain structure; increased activation
during cognitive tasks despite intact performance; and
compromised objective indicators of sleep quality.
According to researchers some of these abnormalities
may persist beyond a month of cessation, but may
resolve within 3 months if cessation is maintained.33
To date, the published evidence base does not clearly
support the concern that legalization of recreational
and/or medical marijuana will lead to increased
marijuana use among adolescents. Several studies have
been conducted, including work that examined the
effect of decriminalization. For example, 2 studies
used data from the Monitoring the Future Study
to examine youth use of marijuana in states that
had decriminalized marijuana and came to different
conclusions. In 1981 Johnston et al34 published data
that showed the decriminalization of marijuana in
some states from 1975 to 1980 did not seem to impact
high school students’ use of marijuana. Chaloupka
et al,35 however, examined data from 1992 to 1994
and found that youth who lived in states that
had decriminalized marijuana were more likely to
report current use and may have used marijuana
more frequently than youth in states that had not
decriminalized marijuana. Ammerman et al32 used
YRBS data to compare marijuana use rates among
youth from states that had legalized medical marijuana
with national use rates. These researchers found no
significant increases or decreases in marijuana use rates
among youth, except in Alaska and New Mexico. New
Mexico showed an increase from 2011 to 2013 among
12th graders, but Alaska showed an 8.5% decrease in
current use rates among youth. More recently, Choo
et al36 found no increase in current use rates after
legalization.
However, Colorado researchers report data that
are consistent with the view that legalization leads
to increased use. They compared the past month
marijuana use by youth in the 2-year average (2013-
2014), this is since Colorado legalized recreational
marijuana, with the 2-year average prior to legalization
(2011-2012). They found rates of past month use 20%
higher in the 2-year period since legalization than in
the 2-year period prior to legalization. The researchers
noted that during the same time period national figures
for past month marijuana use by youth declined by
4%. Also, 2013 to 2014 results show Colorado youth
had the highest rate of past month use of marijuana
in the nation, compared to a #4 ranking in 2011
to 2012, and a #14 ranking in 2005 to 2006. The
2013 to 2014 rate was 74% higher than the national
average. Additionally, the researchers showed that the
10 states that had the highest rate of past month use of
marijuana by youth were all states that had legalized
recreational and/or medical use of marijuana. This was
compared with the 10 states that had the lowest rate of
past month use of marijuana by youth, none of which
had legalized recreational or medical marijuana use.31
The findings of some researchers that have indicated
legalization of recreational and/or medical marijuana
has not impacted youth marijuana use seem counter-
intuitive. As Ammerman,32 however, indicates there
are a number of factors that may influence youth
marijuana use. Some of these may be unrelated to
legalization, per se. Factors such as perception of
social norms, perceived susceptibility to, and perceived
severity of the harmful effects of marijuana, as
well as parent behaviors may influence rates of
marijuana use. The effect of legalization of marijuana
on rates of youth marijuana use, may involve more
than whether or not marijuana use in a particular
state is legal for recreational and/or medical use. It
may depend on the specifics of how legalization is
operationalized.
For example, medical use of marijuana use is now
legal in Kentucky. However, the law, as passed, has a
number of provisions that are problematic for anyone
seeking to use medical marijuana. These include (1)
the law does not make it legal for anyone to grow
marijuana; (2) the use of marijuana is legal only under
the written order of a physician practicing at a hospital
or clinic affiliated with the University of Kentucky or
the University of Louisville—thereby authorizing only
a relatively small group of physicians to participate;
and (3) it is against federal law for a physician to
issue a prescription for marijuana.37 Thus, it seems
reasonable to assume that legalization per Kentucky’s
law will have less influence on increasing rates of
youth marijuana use than legalization in states that
make it easy for adults to legally purchase marijuana
for recreational purposes.
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CONCLUSIONS
Over half of the US states have legalized medical
marijuana and several states have also legalized
recreational use. Marijuana still remains illegal under
federal law, creating a confusing legal landscape.
Although research on the actual effects of marijuana
has been limited, because of its legal status, it is
clear there are some medical benefits. There are also
negative effects, especially indirect effects such as its
negative influence on driving. There are also concerns
about the impact legalization is having on youth
marijuana use. In general it appears that legalization
may increase use among youth, but use may depend
both on the specifics of the legislation and additional
factors not related to the legislation.
IMPLICATIONS FOR SCHOOL HEALTH
An important part of school health programs and the
whole school, whole community, whole child model
is the concept of community involvement.38 One way
schools could involve the community on the matter
of legalizing marijuana for recreational and/or medical
purposes is to sponsor public/community forums on
the issues involved. It is likely that parents and other
community members may have a wide range of
opinions regarding the safety and potential medical
benefits of marijuana. The idea is to provide accurate
information that will allow community members to
make informed decisions. It will be important to
have speakers who are truly experts in the subject
matter, and who can provide a research perspective,
but who are not zealots for or against a particular policy
position. Opportunities should be given for attendees
to ask questions and to share their opinions regarding
policy options.
Additionally, school-based drug education programs
should make every effort to provide accurate infor-
mation to students, including information reflective
of current research, legislation, and legal decisions.
Programs should also continue to discourage young
people from using marijuana. We often hear some
people make the argument that marijuana is no worse
than alcohol or tobacco. Based on the research cur-
rently available, they may be right. Even if they are
right, that’s not much of a recommendation. Remem-
ber 88,000 people die each year in the United States
from alcohol-related deaths39 and tobacco is respon-
sible for 430,000 deaths per year in the United States
(and millions of deaths each year worldwide).40 Thus,
saying something is no worse that alcohol or tobacco,
certainly does not mean it is safe. It is not just the direct
physical effects that are of concern, but also effects on
behavior and decision-making, such as impaired driv-
ing, unsafe sex, and other risky behaviors. Regardless
of legal status, it is important for teachers and parents
to encourage young people to avoid using marijuana
(as well as alcohol, tobacco, and other drugs).
Human Subjects Approval Statement
As a review paper, this work did not require
Institutional Review Board examination.
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